Trial · NCT05014672
Results by group59
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 59
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in ALP at Week 24 Compared to Baseline | Setanaxib 1200 mg/Day | 0.89 | 95% Confidence Interval 0.802 to 0.988 | ratio | |
| Change in ALP at Week 24 Compared to Baseline | Setanaxib 1600 mg/Day | 0.84 | 95% Confidence Interval 0.758 to 0.931 | ratio | |
| Change in ALP at Week 24 Compared to Baseline | Placebo | 1.03 | 95% Confidence Interval 0.936 to 1.141 | ratio | |
| Change in Fatigue at Week 24 Compared to Baseline, as Assessed by the PROMIS Short Form-Fatigue 7b Daily | Setanaxib 1200 mg/Day | -3.60 | 95% Confidence Interval -7.625 to 0.429 | T-scores | |
| Change in Fatigue at Week 24 Compared to Baseline, as Assessed by the PROMIS Short Form-Fatigue 7b Daily | Setanaxib 1600 mg/Day | -0.80 | 95% Confidence Interval -4.679 to 3.072 | T-scores | |
| Change in Fatigue at Week 24 Compared to Baseline, as Assessed by the PROMIS Short Form-Fatigue 7b Daily | Placebo | -1.43 | 95% Confidence Interval -5.331 to 2.461 | T-scores | |
| Change in Fatigue at Week 24 Compared to Baseline, as Assessed by the Patient's Global Impression of Severity (PGIS) Fatigue | Setanaxib 1200 mg/Day | -0.07 | Standard Deviation 0.730 | units on a scale | |
| Change in Fatigue at Week 24 Compared to Baseline, as Assessed by the Patient's Global Impression of Severity (PGIS) Fatigue | Setanaxib 1600 mg/Day | 0.12 | Standard Deviation 0.857 | units on a scale | |
| Change in Fatigue at Week 24 Compared to Baseline, as Assessed by the Patient's Global Impression of Severity (PGIS) Fatigue | Placebo | 0.22 | Standard Deviation 1.003 | units on a scale | |
| Change in Fatigue at Week 24 Compared to Baseline, as Assessed by the Patient's Global Impression of Change (PGIC) Fatigue | Setanaxib 1200 mg/Day | 3.27 | Standard Deviation 1.534 | units on a scale | |
| Change in Fatigue at Week 24 Compared to Baseline, as Assessed by the Patient's Global Impression of Change (PGIC) Fatigue | Setanaxib 1600 mg/Day | 3.62 | Standard Deviation 1.564 | units on a scale | |
| Change in Fatigue at Week 24 Compared to Baseline, as Assessed by the Patient's Global Impression of Change (PGIC) Fatigue | Placebo | 3.58 | Standard Deviation 1.427 | units on a scale | |
| Change in Fatigue at Week 24 Compared to Baseline, as Assessed by the PBC-40 Questionnaire (PBC 40) Fatigue Domain | Setanaxib 1200 mg/Day | -1.44 | 95% Confidence Interval -4.919 to 2.048 | units on a scale | |
| Change in Fatigue at Week 24 Compared to Baseline, as Assessed by the PBC-40 Questionnaire (PBC 40) Fatigue Domain | Setanaxib 1600 mg/Day | -1.83 | 95% Confidence Interval -5.361 to 1.699 | units on a scale | |
| Change in Fatigue at Week 24 Compared to Baseline, as Assessed by the PBC-40 Questionnaire (PBC 40) Fatigue Domain | Placebo | -1.85 | 95% Confidence Interval -5.217 to 1.515 | units on a scale | |
| Change in Liver Stiffness at Week 24 Compared to Screening | Setanaxib 1200 mg/Day | 0.78 | 95% Confidence Interval 0.672 to 0.906 | ratio | |
| Change in Liver Stiffness at Week 24 Compared to Screening | Setanaxib 1600 mg/Day | 0.88 | 95% Confidence Interval 0.764 to 1.012 | ratio | |
| Change in Liver Stiffness at Week 24 Compared to Screening | Placebo | 0.92 | 95% Confidence Interval 0.808 to 1.055 | ratio | |
| Change in Pruritus at Week 24 Compared to Baseline, as Assessed by the Worst Itch Numerical Rating Scale (WI-NRS) | Setanaxib 1200 mg/Day | -0.23 | Standard Deviation 2.280 | units on a scale | |
| Change in Pruritus at Week 24 Compared to Baseline, as Assessed by the Worst Itch Numerical Rating Scale (WI-NRS) | Setanaxib 1600 mg/Day | 0.61 | Standard Deviation 1.391 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05014672/results